Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05910580 · ClinicalTrials.gov registry record · NA

Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years

A NA study of Pregnancy and Contraception, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
4
Study locations

NCT05910580: Recruiting NA study of Pregnancy and Contraception, sponsored by Emory University.

NCT05910580 is a NA study of Pregnancy and Contraception that is actively recruiting participants, run by Emory University. The registered enrollment target is 400 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (54% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05910580, a NA study of Pregnancy and Contraception, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
4
Study locations

Study Summary

The goal of this clinical trial is to test the effectiveness of evidence-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) among adult patients who screen positive to one or more risky alcohol or substance use behaviors while seeking care at a sexual and reproductive health (SRH) clinic. The main questions it aims to answer are: * Does SBIRT impact patients' alcohol and substance use, SRH, mental health, physical health, quality of life, and wellbeing? * Does SBIRT effectiveness differ by ethnicity, socioeconomic status, age, gender, and urbanicity? * Does SBIRT effectiveness differ by delivery mode (in-person vs. telemedicine)? Participants will receive in-person and telemedicine SBIRT, or usual care. Participants will complete surveys at interviews at baseline, 30 days, and 3 months. Researchers will compare patients who received SBIRT to patients who receive usual care to see if patients who receive the SBIRT intervention have a greater reduction in negative outcomes as compared to those who receive usual care. In this setting, usual care consists of basic quantity and frequency questions asked inconsistently as part of the admission process and varying by provider, with no standardized approach to screening, treatment, follow-up, or referral.

Primary Outcome

Participants are asked to self-report the number of drinks consumed on days when alcohol was consumed, during the past 30 days.

Interventions

  • BEHAVIORAL Screening, Brief Intervention, and Referral to Treatment (SBIRT)

Study Locations (4)

Massachusetts

  • Greater Boston Health Center - Boston
  • Metro West Health Center - Marlborough
  • Western Massachusetts Health Center - Springfield
  • Central Massachusetts Health Center - Worcester

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-07-03
Est. Completion 2027-05-31
Phase NA
Emory University

1,208 total trials

What NCT05910580 shows while recruiting

NCT05910580 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (54% lower).

The record links to 10 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Screening, Brief Intervention, and Referral to Treatment (SBIRT) is the first listed.

NCT05910580 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05910580 about?

NCT05910580 is a clinical study titled "Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years". The goal of this clinical trial is to test the effectiveness of evidence-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) among adult patients who screen positive to one or more risky alcohol or substance use behaviors while seeking care at a sexual and reproductive health (SRH...

What is the current status of trial NCT05910580?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-07-03. Estimated completion is 2027-05-31.

What conditions does trial NCT05910580 study?

This clinical trial studies the following conditions: Pregnancy, Contraception, Substance-Related Disorders, Mental Health, Sexually Transmitted Diseases.

What interventions are being tested in trial NCT05910580?

The interventions under investigation include: Screening, Brief Intervention, and Referral to Treatment (SBIRT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05910580?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05910580 being conducted?

This trial has 4 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05910580's enrollment target sits among peer trials

400 58th of 191 higher than 131 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05910580, the US trial registry maintained by the National Library of Medicine. NCT05910580 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.